Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease.
Frans H Rutten, Maarten-Jan M Cramer, Diederick E Grobbee...
https://pubmed.ncbi.nlm.nih.gov/15860516Actively Recruiting
Led by University Hospital, Grenoble · Updated on 2024-06-24
40
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating how impaired oxygen delivery during exercise affects neuromuscular fatigue in patients who have both chronic obstructive pulmonary disease (COPD) and heart failure (HF). These two conditions often occur together and share a common problem of reduced tissue oxygen supply. The study aims to understand whether this oxygen delivery issue leads to more severe muscle and central fatigue during exercise in patients with both COPD and HF compared to those with only COPD. This research also explores ways to improve oxygen delivery and reduce fatigue through specific interventions. The study compares patients with COPD alone who exercise while breathing medical air to patients with both COPD and HF who first exercise under medical air and then under an intervention using a higher oxygen mixture called hyperoxia. These different conditions help researchers assess the effects of improved oxygen delivery. The interventions involve non-invasive treatments during exercise to see how they influence muscle and brain oxygen levels and fatigue. Participants will undergo exercise tests while researchers measure muscle fatigue immediately after exercise, as well as symptoms experienced during exercise, tissue oxygenation, cerebral blood flow, and heart function. The study includes comparisons between the COPD group and the COPD-HF group under medical air, and within the COPD-HF group comparing medical air and hyperoxia. The research team will monitor and assess these factors to better understand the physiological effects and potential benefits of the interventions. The study is expected to continue until December 2025.
CONDITIONS
Neuromuscular Fatigue During Exercise in COPD-HF Overlap
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single session with two exercise exposures
Participants perform exercise tests under medical air and, if assigned to the experimental group, under hyperoxia to evaluate muscle fatigue and physiological responses.
1 visit (in-person)
Total: 1 location
1
CHU Grenoble Alpes - Hopital Sud (Laboratoire HP2)
Échirolles, Auvergne-Rhône-Alpes, France, 38130
Actively Recruiting
S
Stéphane Doutreleau, MD, PhD
M
Mathieu Marillier, PhD
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Frans H Rutten, Maarten-Jan M Cramer, Diederick E Grobbee...
https://pubmed.ncbi.nlm.nih.gov/15860516Mayron F Oliveira, Joel T J Zelt, Joshua H Jones...
https://pubmed.ncbi.nlm.nih.gov/25610401Mayron F Oliveira, Maria Clara Alencar, Flavio Arbex...
https://pubmed.ncbi.nlm.nih.gov/26528895Mayron F Oliveira, Flavio F Arbex, Maria Clara Alencar...
https://pubmed.ncbi.nlm.nih.gov/26790095A Borghi-Silva, C C Oliveira, C Carrascosa...
https://pubmed.ncbi.nlm.nih.gov/18492743Audrey Borghi-Silva, Cláudia Carrascosa, Cristino Carneiro Oliveira...
https://pubmed.ncbi.nlm.nih.gov/18375714Mayron F Oliveira, Miguel K Rodrigues, Erika Treptow...
https://pubmed.ncbi.nlm.nih.gov/22152079